• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2 型糖尿病、糖尿病前期及非糖尿病冠心病患者对乙酰水杨酸的抵抗。

Acetylsalicylic Acid resistance in patients with type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease.

机构信息

Mustafa Cetin, MD, Department of Cardiology, Ankara Numune Education and Research Hospital, Talatpasa Bulvari, 06100, Sihhiye, Ankara, Turkey.

Emrullah Kiziltunc, MD, Department of Cardiology, Ankara Numune Education and Research Hospital, Talatpasa Bulvari, 06100, Sihhiye, Ankara, Turkey.

出版信息

Pak J Med Sci. 2014 May;30(3):539-44. doi: 10.12669/pjms.303.4773.

DOI:10.12669/pjms.303.4773
PMID:24948975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4048502/
Abstract

UNLABELLED

Objective : Several studies have demonstrated the beneficial role of antiplatelet therapy with acetylsalicylic acid (ASA) at atherosclerotic vascular disease. Antiaggregant effect of ASA is not uniform in all patients. Purpose of the present study is to evaluate the prevalence of ASA resistance in patients with type 2 diabetes mellitus (T2DM), pre-diabetes and non-diabetic coronary artery disease (CAD).

METHODS

Effect of ASA was assessed using the platelet function analyzer (PFA-100) system. Resistance to ASA was defined as a normal collagen/epinephrine induced closure time after one week of ASA therapy. Patients with non-diabetic CAD, pre-diabetes and T2DM were compared.

RESULTS

ASA resistance was found in 26 (37.1%), 6 (17.6%) and 41 (26.5%) patients in the groups, respectively (p=0.154). ASA resistance was found to be significantly higher in men, smokers and insulin users, besides this it was found to be significantly lower in beta blocker (BB) users, angiotensin converting enzyme inhibitor (ACEI) users with univariate analysis. However insulin usage was found to be the single effective parameter on ASA resistance in multivariate analysis.

CONCLUSION

There was no difference with regard to ASA resistance between groups. While ASA resistance was higher in men, smokers and insulin users, it was lower in patients using BBs and ACEIs.

摘要

目的

几项研究已经证明了抗血小板治疗用乙酰水杨酸（ASA）在动脉粥样硬化血管疾病中的有益作用。ASA 的抗聚集作用并非在所有患者中都均匀。本研究的目的是评估 2 型糖尿病（T2DM）、糖尿病前期和非糖尿病性冠心病（CAD）患者中 ASA 抵抗的发生率。

方法

使用血小板功能分析仪（PFA-100）系统评估 ASA 的作用。ASA 抵抗定义为在 ASA 治疗一周后正常胶原/肾上腺素诱导的闭合时间。比较了非糖尿病性 CAD、糖尿病前期和 T2DM 患者。

结果

ASA 抵抗分别在组中的 26（37.1%）、6（17.6%）和 41（26.5%）患者中发现（p=0.154）。ASA 抵抗在男性、吸烟者和胰岛素使用者中明显更高，此外，在单变量分析中，β受体阻滞剂（BB）使用者、血管紧张素转换酶抑制剂（ACEI）使用者中发现其明显较低。然而，胰岛素的使用是多变量分析中唯一有效的 ASA 抵抗参数。

结论

各组之间在 ASA 抵抗方面没有差异。虽然 ASA 抵抗在男性、吸烟者和胰岛素使用者中更高，但在使用 BB 和 ACEI 的患者中较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/4048502/6c8fa73a2b52/pjms-30-539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/4048502/6c8fa73a2b52/pjms-30-539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dc0/4048502/6c8fa73a2b52/pjms-30-539-g001.jpg

相似文献

1
Acetylsalicylic Acid resistance in patients with type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease.2 型糖尿病、糖尿病前期及非糖尿病冠心病患者对乙酰水杨酸的抵抗。
Pak J Med Sci. 2014 May;30(3):539-44. doi: 10.12669/pjms.303.4773.
2
Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.同型半胱氨酸是冠心病患者血小板对乙酰水杨酸反应不佳的新的危险因素：一项随机多中心研究。
Pharmacol Res. 2013 Aug;74:7-22. doi: 10.1016/j.phrs.2013.04.010. Epub 2013 May 7.
3
In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease.使用PFA-100的体外出血试验——控制心血管疾病患者个体阿司匹林诱导的血小板抑制的相关方面
J Thromb Thrombolysis. 2001 Dec;12(3):263-72. doi: 10.1023/a:1015231226086.
4
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.经皮冠状动脉介入术后长期服用阿司匹林和氯吡格雷患者中阿司匹林抵抗对血小板功能谱的影响。
Am J Cardiol. 2006 Jan 1;97(1):38-43. doi: 10.1016/j.amjcard.2005.07.106. Epub 2005 Nov 7.
5
Factors responsible for "aspirin resistance" - can we identify them?导致“阿司匹林抵抗”的因素——我们能识别它们吗？
Kardiol Pol. 2010 Apr;68(4):403-11; discussion 412-3.
6
Acetylsalicylic acid (ASA) use among Polish adults with diabetes mellitus.波兰成年糖尿病患者使用乙酰水杨酸（ASA）的情况。
Pol Arch Med Wewn. 2005 Sep;114(3):862-7.
7
The effect of doubling the dose of acetylsalicylic acid (ASA) on platelet function parameters in patients with type 2 diabetes and platelet hyperreactivity during treatment with 75 mg of ASA: a subanalysis of the AVOCADO study.在接受 75 毫克阿司匹林治疗的 2 型糖尿病患者中，双倍剂量乙酰水杨酸（ASA）对血小板功能参数的影响：AVOCADO 研究的亚分析。
Kardiol Pol. 2013;71(6):552-7. doi: 10.5603/KP.2013.0056.
8
Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.2 型糖尿病患者血浆水杨酸浓度与阿司匹林高反应性血小板的相关性。
Cardiol J. 2013;20(2):170-7. doi: 10.5603/CJ.2013.0030.
9
Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.糖尿病中蛋白质糖基化增加与阿司匹林介导的蛋白质乙酰化减少以及血小板对阿司匹林的敏感性降低有关。
J Mol Med (Berl). 2005 Feb;83(2):148-58. doi: 10.1007/s00109-004-0600-x. Epub 2004 Nov 10.
10
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.2 型糖尿病患者阿司匹林治疗期间血小板高反应性的预测因素。
Kardiol Pol. 2013;71(9):893-902. doi: 10.5603/KP.2013.0055.

引用本文的文献

1
Prevalence rate of laboratory defined aspirin resistance in cardiovascular disease patients: A systematic review and meta-analysis.心血管疾病患者中实验室定义的阿司匹林抵抗患病率：一项系统评价和荟萃分析。
Caspian J Intern Med. 2020;11(2):124-134. doi: 10.22088/cjim.11.2.124.
2
Progress on diabetic cerebrovascular diseases.糖尿病性脑血管疾病的研究进展
Bosn J Basic Med Sci. 2014 Nov 9;14(4):185-90. doi: 10.17305/bjbms.2014.4.203.

本文引用的文献

1
Standards of medical care in diabetes--2013.《糖尿病医疗护理标准——2013》
Diabetes Care. 2013 Jan;36 Suppl 1(Suppl 1):S11-66. doi: 10.2337/dc13-S011.
2
Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors.慢性稳定型心绞痛患者的阿司匹林抵抗及其与冠心病危险因素的相关性
Saudi Med J. 2012 Jan;33(1):39-43.
3
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.1 型和 2 型糖尿病患者在慢性阿司匹林治疗下的 COX-1 敏感性和血栓素 A2 生成。
Eur Heart J. 2009 May;30(10):1279-86. doi: 10.1093/eurheartj/ehp097. Epub 2009 Apr 3.
4
Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease.缺血性心脏病患者阿司匹林抵抗的评估随时间而变化。
Heart. 2009 Aug;95(15):1225-9. doi: 10.1136/hrt.2008.150631. Epub 2008 Aug 12.
5
Platelet resistance to the anti-aggregating agents in the insulin resistant states.胰岛素抵抗状态下血小板对抗聚集剂的抵抗性。
Curr Diabetes Rev. 2006 Nov;2(4):409-30. doi: 10.2174/1573399810602040409.
6
Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting.脑血管支架置入术中阿司匹林和氯吡格雷抵抗的患病率及危险因素
AJNR Am J Neuroradiol. 2008 Feb;29(2):281-5. doi: 10.3174/ajnr.A0818. Epub 2007 Nov 7.
7
Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.阿司匹林抵抗：心血管危险因素、既往病史、合并用药及血液流变学变量的可能作用
Drugs Aging. 2006;23(7):559-67. doi: 10.2165/00002512-200623070-00002.
8
Platelet inhibition by insulin is absent in type 2 diabetes mellitus.2型糖尿病患者不存在胰岛素对血小板的抑制作用。
Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):417-22. doi: 10.1161/01.ATV.0000199519.37089.a0. Epub 2005 Dec 8.
9
A new definition of aspirin non-responsiveness by platelet function analyzer-100 and its predictors.血小板功能分析仪-100对阿司匹林无反应性的新定义及其预测因素
Platelets. 2006 Feb;17(1):7-13. doi: 10.1080/09537100500163358.
10
Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes.糖尿病患者中，通过血小板功能分析仪（PFA-100）测定增加剂量阿司匹林对血小板功能的影响。
Thromb Res. 2005;116(6):465-70. doi: 10.1016/j.thromres.2005.02.005.